A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2002
08/29/2002	WO2001064206A3 Inhibitors of melanocyte tyrosinase as topical skin lighteners
08/29/2002	WO2001062238A3 Ppar gamma agonists for the treatment of liver inflammatory disorders
08/29/2002	WO2001041758A8 Valnemulin formulation
08/29/2002	WO2001037785A9 Novel methods and compositions involving opioids and antagonists thereof
08/29/2002	WO2001035941A8 Novel composition based on a thiazolidinedione and metformin and use
08/29/2002	WO2001032158A3 Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent
08/29/2002	WO2001017530A9 Iron chelators and uses thereof
08/29/2002	WO2001017364A9 Food product and process for manufacturing same
08/29/2002	WO2001012584A3 Pharmaceutical compounds
08/29/2002	WO2001010422A9 Use of hepoxilins or hepoxilin analogs as antidiabetics, antiinframmatory agents
08/29/2002	WO2001008670A3 Methods and compositions for alleviating stuttering
08/29/2002	WO2001005792A9 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use
08/29/2002	WO2001005427A9 Psca: prostate stem cell antigen and uses thereof
08/29/2002	WO2001005373A9 Methods and apparatus for preparation of lipid vesicles
08/29/2002	WO2001001980A9 Methods for the amelioration of neuropsychiatric disorders by inhibiting the inactivating transport of endogenous cannabinoid substances
08/29/2002	WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002	WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002	WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002	WO2000064443A9 Synergistic effects of amlodipine and atorvastatin
08/29/2002	WO2000063245A9 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
08/29/2002	WO2000061788A3 Poly(dipeptide) as a drug carrier
08/29/2002	WO2000059515A9 Immunomodulating polymers
08/29/2002	WO2000055330A9 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans
08/29/2002	WO2000040543A9 Skin whitener
08/29/2002	WO2000034474A9 Growth factor homolog zvegf3
08/29/2002	WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b
08/29/2002	WO2000010981A9 Quinazoline derivatives
08/29/2002	WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002	US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen
08/29/2002	US20020120156 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate
08/29/2002	US20020120152 Aminoaryl oxazolidinone N-oxides
08/29/2002	US20020120149 Substituted hydrazine derivatives
08/29/2002	US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002	US20020120147 Micronized torsemide
08/29/2002	US20020120145 Inhibiting farnesyl protein transferase.
08/29/2002	US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them
08/29/2002	US20020120123 Human vascular endothelial growth factor 2
08/29/2002	US20020120103 17 human secreted proteins
08/29/2002	US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
08/29/2002	US20020120099 Novel cyclic tetrapeptide derivatives and pharmaceutical uses thereof
08/29/2002	US20020120098 Enhanced stimulation of erythropoiesis
08/29/2002	US20020120014 Rhinologically active substances
08/29/2002	US20020120013 Regulation of phospholipase D activity
08/29/2002	US20020120012 Methods of treating androgen deficiency in men using selective antiestrogens
08/29/2002	US20020120010 Increasing and enhancing the quantity and quality of normal spermatozoa in male mammals
08/29/2002	US20020120009 Compounds and compositions for delivering active agents
08/29/2002	US20020120008 Life extension of drosophila by a drug treatment
08/29/2002	US20020120007 Benzamide inhibitors of factor Xa
08/29/2002	US20020120006 Administering benzyl, naphthyl acid derivatives
08/29/2002	US20020120003 Methods for decreasing beta amyloid protein
08/29/2002	US20020120002 2-tri-halo-1-methyl-N-acetyl-5-methoxytryptamine and a carrier
08/29/2002	US20020120001 Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect
08/29/2002	US20020119999 Imidazole dione or one, thione derivatives as antitumor and antiinflammatory agents, also treats cardiovascular disease, nephropathies and retinopathies
08/29/2002	US20020119997 Aqueous solution; topical applying
08/29/2002	US20020119994 LFA-1 Antagonist compounds
08/29/2002	US20020119993 Nervous system disorders
08/29/2002	US20020119992 Anticoagulants
08/29/2002	US20020119990 Liposomal camptothecins and uses thereof
08/29/2002	US20020119989 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
08/29/2002	US20020119988 Modulators of TNF-alpha signaling
08/29/2002	US20020119987 Analgesics, anesthetic; side effect reduction
08/29/2002	US20020119986 Heteroaryl- phenyl heterobicyclic factor Xa inhibitors
08/29/2002	US20020119984 Azole compounds as anti-fungal agents
08/29/2002	US20020119983 Novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
08/29/2002	US20020119982 Antiviral azaindole derivatives
08/29/2002	US20020119981 Novel N-substituted urea inhibitors of farnesyl-protein transferase
08/29/2002	US20020119978 Composition and method for decreasing neurologic symptomatology
08/29/2002	US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
08/29/2002	US20020119976 Tetracyclic derivatives, process of preparation and use
08/29/2002	US20020119975 Autoimmune disease; antiinflammatory agents; antiallergens; antiproliferative agents; anticancer agents
08/29/2002	US20020119974 Administering guanosine cyclic 3',5'-monophosphate; phosphodiesterase inhibitor
08/29/2002	US20020119973 Antiinflammatory agents
08/29/2002	US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
08/29/2002	US20020119971 Antiinflammatory agents; skin disorders; central nervous system disorders
08/29/2002	US20020119970 Method for treating glaucoma IIB
08/29/2002	US20020119969 Potassium channel modulator; antidiabetic agents
08/29/2002	US20020119968 Protease inhibitor
08/29/2002	US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor
08/29/2002	US20020119966 Central nervous system disorders
08/29/2002	US20020119965 Nitriloxy derivatives of (R) and (S)-carnitine
08/29/2002	US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
08/29/2002	US20020119961 Bridged piperazine derivatives
08/29/2002	US20020119960 Drug resistance therapy
08/29/2002	US20020119959 Estrogenic compounds as anti-mitotic agents
08/29/2002	US20020119958 Therapeutic agent for hyperlipidemia
08/29/2002	US20020119956 Using thalidomine
08/29/2002	US20020119955 Modified prodrug forms of AP/AMP
08/29/2002	US20020119954 Mixture with polysiloxane
08/29/2002	US20020119953 Sickle cell anemia
08/29/2002	US20020119950 Administering mixture of aminosugar with ergothionine, diacetin, arachadonic acid and tatracyclic antibiotic
08/29/2002	US20020119949 Prophylactic teat treatment
08/29/2002	US20020119946 Formative agent of protein complex
08/29/2002	US20020119945 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof
08/29/2002	US20020119939 Stable aqueous deoxyfructosazine solution
08/29/2002	US20020119938 Antibiotics
08/29/2002	US20020119936 Composition & method for reducing adenosine levels with a ubiquinone and optionally a dehydroepiandrosterone
08/29/2002	US20020119935 Triterpenes having antibacterial activity
08/29/2002	US20020119934 Methods for using specific saccharides for treating Alzheimer's disease and other amyloidoses
08/29/2002	US20020119933 Administering ribose; cardiovascular disorders
08/29/2002	US20020119924 Combination therapy using a TNF binding protein for treating TNF-mediated diseases

1 ... 5726 5727 5728 5729 5730 5731 5732 5733 5734 5735 5736 5737 5738 5739 5740 5741 5742 5743 5744 5745 5746 ... 7860